Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein
Sudhakar R. Subramaniam, Iddo Magen, Nicholas Bove, et al.
Neurobiology of Disease (2018) Vol. 117, pp. 170-180
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn (“line 61”) Mice
Franziska Richter, Miloš Stanojlović, Christopher Käufer, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 1, pp. 97-116
Open Access | Times Cited: 23
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Érica Novaes Soares, Ana Carla dos Santos Costa, Gabriel de Jesus Ferrolho, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 474-474
Open Access | Times Cited: 11
Non-polyphenolic natural inhibitors of amyloid aggregation
Liang Ma, Chen Yang, Jiaojiao Zheng, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112197-112197
Closed Access | Times Cited: 53
Nicotine‐Mediated Rescue of α‐Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in Drosophila
Abby L. Olsen, Sabrina G. Clemens, Mel Β. Feany
Movement Disorders (2022) Vol. 38, Iss. 2, pp. 244-255
Open Access | Times Cited: 26
Ginsenoside Rb1 prevents MPTP-induced changes in hippocampal memory via regulation of the α-synuclein/PSD-95 pathway
Shaogang Qu, Xingjun Meng, Yan Liu, et al.
Aging (2019) Vol. 11, Iss. 7, pp. 1934-1964
Open Access | Times Cited: 37
Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
Mohamed Bilal Fares, Omar Alijevic, Stéphanie Johne, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 12
Central nervous system interaction and crosstalk between nAChRs and other ionotropic and metabotropic neurotransmitter receptors
Federica Bono, Chiara Fiorentini, Veronica Mutti, et al.
Pharmacological Research (2023) Vol. 190, pp. 106711-106711
Open Access | Times Cited: 11
Nicotine Ameliorates α-Synuclein Preformed Fibril-Induced Behavioral Deficits and Pathological Features in Mice
Zhangqiong Huang, Yue Pan, Kaili Ma, et al.
Applied Biochemistry and Biotechnology (2025)
Open Access
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer
Federica Bono, Veronica Mutti, Paola Savoia, et al.
Neurobiology of Disease (2019) Vol. 129, pp. 1-12
Closed Access | Times Cited: 33
Neuropsychiatric and Cognitive Deficits in Parkinson’s Disease and Their Modeling in Rodents
Mélina Decourt, Haritz Jiménez‐Urbieta, Marianne Benoit‐Marand, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 684-684
Open Access | Times Cited: 25
Cognitive dysfunction in animal models of human lewy-body dementia
Caroline Haikal, Graham M. Winston, Michael G. Kaplitt
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 3
How Well Do Rodent Models of Parkinson’s Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review
Tracy D. Zhang, Scott Kolbe, Leah C. Beauchamp, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3026-3026
Open Access | Times Cited: 16
Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson’s disease model
Chunni Zhu, Tina Bilousova, Samantha Focht, et al.
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease
Aleksandar Dobric, Simone N. De Luca, Sarah J. Spencer, et al.
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108017-108017
Open Access | Times Cited: 19
Mouse Model of Parkinson’s Disease with Bilateral Dorsal Striatum Lesion with 6-Hydroxydopamine Exhibits Cognitive Apathy-like Behavior
Masato Okitsu, Masayo Fujita, Yuki Moriya, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7993-7993
Open Access | Times Cited: 2
Under or Absent Reporting of Light Stimuli in Testing of Anxiety-Like Behaviors in Rodents: The Need for Standardization
Lorenz S. Neuwirth, Michael T. Verrengia, Zachary I. Harikinish-Murrary, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 11
The Role of Nicotinic Receptors in the Attenuation of Autism‐Related Behaviors in a Murine BTBR T + tf/J Autistic Model
Hafiz Majid Mahmood, Hesham Aldhalaan, Tahani K. Alshammari, et al.
Autism Research (2020) Vol. 13, Iss. 8, pp. 1311-1334
Closed Access | Times Cited: 16
Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy
Chia‐Chen Hsu, Yu–Fu Su, Kuo‐Yang Tsai, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Activation of α7-nAChRs Promotes the Clearance of α-Synuclein and Protects Against Apoptotic Cell Death Induced by Exogenous α-Synuclein Fibrils
Jifeng Zhao, Yun Li, Yan Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 13
Impact of Electronic Cigarette Vaping on Cerebral Ischemia: What We Know So Far
Jonathan H. Siegel, Shahil H. Patel, Berk Mankaliye, et al.
Translational Stroke Research (2022) Vol. 13, Iss. 6, pp. 923-938
Closed Access | Times Cited: 9
Activation of α7‐nAChRs protects SH‐SY5Y cells from 1‐methyl‐4‐phenylpyridinium‐induced apoptotic cell death via ERK/p53 signaling pathway
Shi Xu, Beibei Yang, Tingting Tao, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 10, pp. 18480-18491
Closed Access | Times Cited: 15
α-synuclein overexpression and the microbiome shape the gut and brain metabolome in mice
Lívia H. Morais, Joseph C. Boktor, Siamak MahmoudianDehkordi, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 1
Behavioral Deficits and Brain α-Synuclein and Phosphorylated Serine-129 α-Synuclein in Male and Female Mice Overexpressing Human α-Synuclein
Lilit Gabrielyan, Honghui Liang, Artem Minalyan, et al.
Journal of Alzheimer s Disease (2020) Vol. 79, Iss. 2, pp. 875-893
Open Access | Times Cited: 6
Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson’s Disease
Yijuan Du, Steven M. Graves
Frontiers in Neural Circuits (2019) Vol. 13
Open Access | Times Cited: 4
A Call for Drug Therapies for the Treatment of Social Behavior Disorders in Dementia: Systematic Review of Evidence and State of the Art
Chiara Cerami, Giulia Perini, Andrea Panzavolta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11550-11550
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top